Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Accumulated Depreciation: 2024

  • Pyxis Oncology's Accumulated Depreciation was N/A to $5.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $5.2 million, marking a year-over-year change of. This contributed to the annual value of $5.2 million for FY2024, which is N/A change from last year.
  • As of Q4 2024, Pyxis Oncology's Accumulated Depreciation stood at $5.2 million.
  • Pyxis Oncology's 5-year Accumulated Depreciation high stood at $5.2 million for Q4 2024, and its period low was $5.2 million during Q4 2024.
  • In the last 1 years, Pyxis Oncology's Accumulated Depreciation had a median value of $5.2 million in 2024 and averaged $5.2 million.